https://www.selleckchem.com/products/2-nbdg.html
CrI 0.45, 1.01; pp = 0.97). CSII therapy was associated with marked falls in HbA especially in those with high baseline HbA . CSII was independently associated with reduced DKA and SHH rates. CSII appears to be an effective option for intensive insulin therapy in people with diabetes for improving suboptimal glycaemic control. CSII therapy was associated with marked falls in HbA1c especially in those with high baseline HbA1c. CSII was independently associated with reduced DKA and SHH rates. CSII appears to be an effective option for inte